Back to Search
HUNTER HOLLOWAY, PH.D.
PH.D.
Psychologist
NPI: 1346802063Individual
Specialties, Licenses & Credentials
PsychologistPrimary
Psychologist
Code: 103T00000X
1474(OK)
Research & Publications (20)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
PMID 19164583·Proc Natl Acad Sci U S A·2009
7-preclinical
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
PMID 19583982·J Neurosci Methods·2009
7-preclinical
Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis.
PMID 18235987·J Neural Transm (Vienna)·2008
8-other
Alternatively spliced forms of the P180 ribosome receptor differ in their ability to induce the proliferation of rough endoplasmic reticulum.
PMID 18083570·Cell Biol Int·2008
7-preclinical
Models of PTSD and traumatic stress: the importance of research "from bedside to bench to bedside".
PMID 18037016·Prog Brain Res·2008
6-review
Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine.
PMID 17985237·Neurochem Res·2008
8-other
Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice.
PMID 17999205·Neuromolecular Med·2007
7-preclinical
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy.
PMID 17125767·Exp Neurol·2007
7-preclinical
Apoptotic and behavioral sequelae of mild brain trauma in mice.
PMID 17243171·J Neurosci Res·2007
7-preclinical
The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
PMID 17003227·J Pharmacol Exp Ther·2007
7-preclinical
Preclinical investigation of the topical administration of phenserine: transdermal flux, cholinesterase inhibition, and cognitive efficacy.
PMID 17255466·J Pharmacol Exp Ther·2007
7-preclinical
Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide.
PMID 16690718·J Pharmacol Exp Ther·2006
7-preclinical
Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental Alzheimer therapeutic, bisnorcymserine.
PMID 16988481·J Alzheimers Dis·2006
8-other
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.
PMID 16570913·J Med Chem·2006
7-preclinical
Intravenous butyrylcholinesterase administration and plasma and brain levels of cocaine and metabolites in rats.
PMID 15967428·Eur J Pharmacol·2005
4-observational
Syntheses of tetrahydrofurobenzofurans and dihydromethanobenzodioxepines from 5-hydroxy-3-methyl-3H-benzofuran-2-one. Rearrangement and ring expansion under reductive conditions on treatment with hydrides.
PMID 16050674·J Org Chem·2005
8-other
Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects.
PMID 16248851·Curr Alzheimer Res·2005
3-trial
War correspondents as responders: considerations for training and clinical services.
PMID 16253114·Psychiatry·2005
8-other
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.
PMID 16275899·Proc Natl Acad Sci U S A·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3035 NW 63RD ST STE 227
OKLAHOMA CITY, OK 73116 - Phone
- (405) 242-6460
Quick Facts
- NPI
- 1346802063
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile